We use cookies to help provide you with the best possible online experience. Please read our Privacy Policy for information about which cookies we use and what information we collect on our site. By continuing to use this site, you agree that we may store and access cookies on your device.
InFlectis BioScience has been granted exclusive patent rights from the University of Chicago to use a family of small molecules for the treatment of demyelinating diseases.
Case studies featuring "Light-out Factory", "Society 5.0" and developments in additive manufacturing, IIoT, industry 4.0 across aerospace, pharma, electronics, automotive, chemical industries are major highlights at CMT's Manufacturing Automation Asia on